Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H26N2O3 |
| Molecular Weight | 354.4427 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCC4=C(NC5=C4C=CC=C5)[C@H]3C[C@H]12
InChI
InChIKey=BLGXFZZNTVWLAY-AECJZGCLSA-N
InChI=1S/C21H26N2O3/c1-26-21(25)19-15-10-17-20-14(13-4-2-3-5-16(13)22-20)8-9-23(17)11-12(15)6-7-18(19)24/h2-5,12,15,17-19,22,24H,6-11H2,1H3/t12-,15-,17+,18-,19+/m0/s1
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL1907610 Sources: https://www.ncbi.nlm.nih.gov/pubmed/6103816 |
2.5 µM [Ki] | ||
Target ID: CHEMBL2093864 Sources: https://www.ncbi.nlm.nih.gov/pubmed/6103816 |
1.9 µM [Ki] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
PubMed
| Title | Date | PubMed |
|---|---|---|
| Inhibition by yohimbine of the calcium-dependent evoked release of [3H]GABA in rat and mouse brain slices in vitro. | 1985-04-23 |
|
| Functional characterization of central alpha-adrenoceptors by yohimbine diastereomers. | 1981-03-05 |
|
| Antagonist/agonist-preferring alpha-adrenoceptors or alpha 1/alpha 2-adrenoceptors? | 1980-05-02 |
|
| Stereoselective total syntheses of (plus minus)-yohimbine, (plus minus)-psi-yohimbine, and (plus minus)- -yohimbine. | 1972-07-12 |
|
| [Certain pharmacological properties of pseudoyohimbine]. | 1955-06 |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2990943
Pseudoyohimbine, in concentrations up to 10 uM, did not affect the stimulation-evoked release of [3H]GABA in rat and mouse brain slices in vitro.
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
84-37-7
Created by
admin on Mon Mar 31 23:02:50 GMT 2025 , Edited by admin on Mon Mar 31 23:02:50 GMT 2025
|
PRIMARY | |||
|
141949
Created by
admin on Mon Mar 31 23:02:50 GMT 2025 , Edited by admin on Mon Mar 31 23:02:50 GMT 2025
|
PRIMARY | |||
|
PJ26Z3D476
Created by
admin on Mon Mar 31 23:02:50 GMT 2025 , Edited by admin on Mon Mar 31 23:02:50 GMT 2025
|
PRIMARY | |||
|
DTXSID701018972
Created by
admin on Mon Mar 31 23:02:50 GMT 2025 , Edited by admin on Mon Mar 31 23:02:50 GMT 2025
|
PRIMARY | |||
|
72116
Created by
admin on Mon Mar 31 23:02:50 GMT 2025 , Edited by admin on Mon Mar 31 23:02:50 GMT 2025
|
PRIMARY | |||
|
251562
Created by
admin on Mon Mar 31 23:02:50 GMT 2025 , Edited by admin on Mon Mar 31 23:02:50 GMT 2025
|
PRIMARY | |||
|
m9301
Created by
admin on Mon Mar 31 23:02:50 GMT 2025 , Edited by admin on Mon Mar 31 23:02:50 GMT 2025
|
PRIMARY | Merck Index |
ACTIVE MOIETY